When: Thursday, September 20, 2018 4:00 - 7:00 PM EST

Where: Columbus Center 701 E Pratt St Baltimore, MD 21202

Join us in envisioning a future that weaves together big data scientists with makers, medical doctors with apparel designers, cut & sew craftsman with artificial intelligence coders. An evening of looking back on the textile mills that once built our city and seeing the new mills of tomorrow filled with smart garments, technical textiles and wearables. Visit the displays of Baltimore companies with athletic apparel, high fashion and medical devices made with functional textiles. Most importantly, see how this new fabric of Baltimore engages you.

Silver Spring-based United Therapeutics Corp. announced Tuesday that it will pay a California company $95 million to develop a new form and delivery method of its flagship Remodulin drug to treat pulmonary arterial hypertension.

BrainScope today announced that it has been awarded a research contract by the United States Department of Defense (DOD) valued at $4.5 million to create and integrate ocular capabilities into its handheld, multi-parameter mild Traumatic Brain Injury (mTBI) and concussion products. 

In healthcare, immersive technology has a number of benefits. Many of these have been demonstrated in a number of ways, whether that is through distracting from pain, or helping to train new doctors. One of the most promising is how virtual reality (VR) can assist in surgery. This technology is being introduced to the Children’s National Health System in Washington D.C.

You have one week left to submit your proposal for our $100K pediatric pitch competition focused on pediatric cardiovascular devices that meet a significant unmet need. The submission deadline is Sept. 10.

If chosen as a finalist, you will have an opportunity to pitch your device to our distinguished panel of judges on Sept. 23 as part of our annual pediatric device symposium.

A new space designed to promote student entrepreneurship is open near Johns Hopkins University's Homewood campus as the school welcomes students back to campus this week.

A George Mason University researcher is heading a scientific team that has received a sizable Department of Defense grant to combat the threat of a South American disease that can cause long-term neurological problems and even death.

Orthopedics company Stryker announced Thursday that it is buying K2M Group Holdings, a maker of 3-D printed implantable, minimally invasive spine products, for $1.4 billion. Analysts reacted positively pointing out that while a small player K2M will help to boost Stryker’s spine division that has not been performing well as of late.

When: Thursday, September 6, 2018 from 4:30 PM to 7:30 PM EDT

Where: Columbus Center - Baltimore 701 E Pratt St Baltimore, MD 21202

Join us for this exclusive CEO Talks panel event on September 6th in Baltimore!

The second installment of the #CEOTalks event series will bring you insights from local company executives on the game changing technologies they are bringing to market to address one of the greatest public health threats of our age; Anti-microbial Resistance (AMR). 

Bringing new treatments to market in this field is made harder by a unique set of market conditions and investment hurdles that executives need to navigate to be successful.

The Institute for Bioscience and Biotechnology Research (IBBR) has entered into two separate collaborations involving its polyphosphazene (PPZ) polymer platform. PPZs are synthetic, biofunctional macromolecules with the potential to advance a wide range of biomedical capabilities. IBBR Fellow, Dr. Alexander Andrianov, is working with collaborators to develop new PPZs for use as coatings for medical devices and as carriers of medical imaging agents.

For entrepreneurs and small business owners, innovation is essential. It differentiates them from their similar-sized competitors, and it’s what allows them to compete with much larger organizations and still thrive.

In just a week’s time, Life Science Nation will be bringing the Redefining Early Stage Investments (RESI) Conference back to the Marriott Copley Place in downtown Boston. Over 700 attendees from the early stage life science world will be at RESI, including startups at the earliest stages of development representing tech hubs from all around the US Northeast in the new RESI Innovator’s Gathering, plus over 300 investors. You can read the program guide below to plan out your day at RESI and see who else will be there. We look forward to seeing you next week.

When: Thursday, September 13, 2018 from 5:00 PM to 7:30 PM EDT

Where: Bar Louie 150 Gibbs St Rockville, MD 20850

Please join us next month at BioBuzz and meet this year's 'Buzz of BIO' winner and Annual BioBuzz Sponsor, Immunomic Therapeutics (ITI), at Bar Louie in Rockville on September 13th. 
Get to know the team behind the company that is receivivng such widespread industry attention for the recent evolution of their innovative technology platform, UNITE, which has the potential to alter how we use immunotherapy for cancer, allergies and animal health.

At each stage of growth for a life sciences firm, the funding needs change. Learn about the different types of capital investors and which ones might work best for your firm as a funding source.

emocha Mobile Health, a Baltimore-based company whose video-based technology helps people take their medications as directed, has been awarded a Small Business Innovation Research (SBIR) award from the National Institute On Minority Health And Health Disparities (NIMHD) of the National Institutes of Health (NIH). The award gives emocha an additional $1 million over two years to evaluate its medication adherence platform for patients with tuberculosis (TB) in several sites throughout the United States. Researchers at the Johns Hopkins University School of Medicine will conduct the evaluation.

The 2019 FLC awards are now open for nominations.  One of the most coveted honors in the technology transfer field, the FLC awards have been presented to over 200 federal laboratories since their inception in 1984. Many winning technology transfer efforts have gone on to become products and devices that are indispensable in our daily lives.

The U.S. Small Business Administration (SBA) has granted 24 awards for $125,000 in FY 2018 under the Federal and State Technology (FAST) Partnership Program. Recipients include state and local economic development entities, Small Business Technology Development Centers, Women's Business Centers, incubators, accelerators, colleges, and universities that provide support to small businesses developing and commercializing high risk technologies.  

Massachusetts' renowned biotech cluster has relinquished its top spot on the ranking of states with the highest research and development employment to its longtime West Coast rival.

The state of Maryland has matched a donation from the family of Google co-founder Sergey Brin to endow two professorships in computer science at the University of Maryland, College Park, the university announced Wednesday. The $1 million from the state will match a private donation to endow the Brin Family Endowed Professorships in Theoretical Computer Science.

As part of its 30+ year commitment to foster the growth of exceptional and promising market-leading companies from founding to exit, the Mid-Atlantic Venture Association (MAVA) is proud to announce that 16 companies will take the stage at TechBUZZ Fall 2018 on Thursday, September 20, 2018 in College Park, Maryland from 10:00am – 7:00pm at The Hotel at the University of Maryland. TechBUZZ, a ticketed business program hosted three times annually, is MAVA’s flagship seed and early-stage program dedicated to the support of the earliest of market-ready tech and tech-enabled companies across industry sector.

Baltimore biotech company PathSensors is looking to enter the Chinese market.

Emergent BioSolutions Inc. (EBS) announced today that it has entered into an agreement to acquire Adapt Pharma and its flagship product NARCAN® (naloxone HCl) Nasal Spray, the first and only needle-free formulation of naloxone approved by the U.S. Food and Drug Administration (FDA) and Health Canada, for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. Total consideration for the transaction is up to $735 million consisting of an upfront payment of $635 million and up to $100 million in cash for potential sales-based milestones through 2022. The upfront payment of $635 million consists of $575 million in cash and $60 million in Emergent common stock, all of which are subject to certain adjustments under the terms of the agreement.

Inova Fall Entrepreneur Program  FREE 3-month series designed to provide entrepreneurs a comprehensive set of skills required to execute the commercialization and growth of healthtech companies

Network & learn from industry leaders - speakers from NEA, Merritt Group, Wilson Sonsini Goodrich & Rosati, MPR Associates, Center for Innovative Technology, and more!

More than 20 companies in Montgomery County made this year’s list of Inc. 5000 fastest growing companies. The report, published, earlier this week, ranked the fastest-growing private companies across the nation.

Mindoula Health in Silver Spring was ranked the highest in the county coming in at No. 36. According to the report, Mindoula grew by 7,310 percent in the last three years.

Baltimore health technology startup b.well Connected Health has raised millions of dollars in funding to support big growth plans.

According to four separate documents recently filed with the U.S. Securities and Exchange Commission, b.well has raised a total of $8.2 million in convertible debt funding from more than 60 investors.

MedImmune has been named one of The Washington Post’s 2018 Top Workplaces in the Washington, D.C. area. Selection is based solely on employee feedback, which measured several aspects of workplace culture, including alignment, execution, and connection.

Johns Hopkins University School of Medicine leaders plan to invest $100 million over the next five years to hire new faculty and support programs aimed at unraveling the mysteries of biology. Such “basic” science discoveries underpin virtually every major medical breakthrough, say the leaders, and they have appointed structural biologist James Berger, Ph.D., to direct the Johns Hopkins institute dedicated to this effort.

State Profiles is an interactive website providing access to state-level data on science and engineering (S&E) personnel and finances and state rankings. State Profiles displays up to 7 state profiles of the user’s choice. Data are available from surveys sponsored by the National Science Foundation on employed science, engineering, or health (SEH) doctorate holders; S&E doctorates awarded, including by major S&E fields; SEH graduate students and postdoctorates; federal research and development obligations by agency and performer; total and business R&D expenditures; and higher education R&D performance, including by major S&E fields. Data available from other sources include population, civilian labor force, per capita personal income, federal expenditures, patents, small business innovation research awards, and gross domestic product. All data are available for download. Data cover 2003 to present.

Scientists have developed a way to grow miniature versions of human organs; some of the weirdest organoids are the mini brains.

The majority of healthcare organizations — 63 percent — say they are planning to invest more than $1 million into blockchain in 2019, according to a Deloitte report.

Deloitte conducted an online survey of 1,053 senior executives from companies with at least $500 million in annual revenue from seven countries — Canada, China, France, Germany, Mexico, the United Kingdom and the United States — between March 26 and April 5 for its global blockchain report.

Francis Collins did not take off his pants.

To the contrary, he could sense something wasn’t quite right — perhaps immediately, when his heavyset and dubiously bearded interviewer, sitting in a motorized scooter, began by asking: “Why are big agriculture putting chemicals into our food to make people transgender?”

In 2019, the Foundation for the National Institutes of Health (FNIH) will present the seventh annual Lurie Prize in Biomedical Sciences, a $100,000 award recognizing outstanding achievement by a promising young scientist in biomedical research. The Prize is made possible by a generous gift from philanthropist Ann Lurie.

The awardee will be selected by a jury of six distinguished biomedical researchers, chaired by Solomon H. Snyder, M.D., Distinguished Service Professor of Neuroscience, Pharmacology & Psychiatry, The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine.

The Award will be presented at the FNIH Award Ceremony on Wednesday, May 22, 2019 in Washington, D.C.

One of Maryland’s best-funded biotech companies took a milestone first step Monday, announcing it has begun clinical trials of a medication it is developing. Gaithersburg-based Viela Bio was spun out of MedImmune, a subsidiary of AstraZeneca, last month with $250 million in financing and a promise of creating 100 jobs within five years.

AAVogen Inc., a biotech company that is developing gene therapeutics for muscle wasting disease, welcomes Lawson Macartney, DVM/PhD as the newest member of its Science Advisory Board.

Dr. Macartney is a 25-year veteran of the pharmaceutical industry and currently chairs the Board of Directors for Viking Therapeutics. He has also held senior leadership positions at Ambrx, ScoutBio, Shire, GlaxoSmithKline and AstraMerck.

MedImmune is one of the 300+ BioHealth success stories in Montgomery County. Meet JoAnn Suzich, Ph.D., VP of Research and Microbial Sciences, who shares the incredible health innovation happening on MedImmune’s campus in Montgomery County.